← Leaderboards

Ronald J Falk

University Of North Carolina Chapel Hill

Google Scholar ↗PubMed ↗ORCID ↗

$26,386,981

Attributed

$29,810,950

Total exposure

20

Grants

17

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.3M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$57,135,608 · 22

By mechanism

P01$35,274,366 · 12

U01$5,840,354 · 1

T32$5,453,192 · 1

UM1$3,998,872 · 1

R01$3,603,644 · 2

U2C$2,276,131 · 2

Top collaborators

Most similar at University Of North Carolina Chapel Hill

Same institution · by research overlap

Brian P O'Connor$3,242,781
Melanie S Joy$4,717,709
Darrel W Stafford$14,989,135
J. Charles Jennette$2,423,729
Susan L Hogan$3,706,530

Others in their field

Top investigators on “Glomerulonephritis”

Tanya N. Mayadas · Brigham And Women'S Hospital$18,682,896
Ali G Gharavi · Mount Sinai School Of Medicine Of Nyu$16,743,333
Lawrence B. Holzman · University Of Michigan At Ann Arbor$14,822,716
Gregory S Hageman · University Of Iowa$14,773,700
Jan Novak · University Of Alabama At Birmingham$12,070,770
Wenchao Song · University Of Pennsylvania$11,570,524

Research focus

GlomerulonephritisKidneyCohortTrainingProgramsPathogenesisKidney DiseasesClinical ResearchGrantNeutrophilCellsAutoantibodiesAutoimmune DiseasesBaseDisease RemissionAutoantigensEpigenetic ProcessAntibodiesResearch PersonnelEpidemiologyVasculitisAutoimmune ProcessBiologyDiagnosis

Grant awards (132)

CureGN-3: UNCPCC$812,505

U01 · FY2025 · DK · contact PI

U2C/TL1 NC KUH TRIO Program$488,177

U2C · FY2025 · DK · contact PI

TRIO Administrative Core$310,555

U2C · FY2025 · DK · contact PI

CureGN-3: UNCPCC$34,830

U01 · FY2025 · DK · contact PI

CureGN-3: UNCPCC$924,999

U01 · FY2024 · DK · contact PI

Pathobiology of ANCA Glomerulonephritis: Targeting Adaptive and Innate Immune Processes for Precision Therapies$653,602

R01 · FY2024 · DK · contact PI

U2C/TL1 NC KUH TRIO Program$439,360

U2C · FY2024 · DK · contact PI

TRIO Administrative Core$272,033

U2C · FY2024 · DK · contact PI

CureGN-2: UNCPCC$779,807

U01 · FY2023 · DK · contact PI

Pathobiology of ANCA Glomerulonephritis: Targeting Adaptive and Innate Immune Processes for Precision Therapies$682,709

R01 · FY2023 · DK · contact PI

U2C/TL1 NC KUH TRIO Program$488,177

U2C · FY2023 · DK · contact PI

TRIO Administrative Core$277,829

U2C · FY2023 · DK · contact PI

CureGN-2: UNCPCC$779,807

U01 · FY2022 · DK · contact PI

Pathobiology of ANCA Glomerulonephritis: Targeting Adaptive and Innate Immune Processes for Precision Therapies$679,218

R01 · FY2022 · DK · contact PI

Renal Epidemiology Training Grant$269,810

T32 · FY2022 · DK · contact PI

CureGN-2: UNCPCC$948,790

U01 · FY2021 · DK · contact PI

Pathobiology of ANCA Glomerulonephritis: Targeting Adaptive and Innate Immune Processes for Precision Therapies$677,829

R01 · FY2021 · DK · contact PI

Renal Epidemiology Training Grant$281,699

T32 · FY2021 · DK · contact PI

Renal Epidemiology Training Grant$49,519

T32 · FY2021 · DK · contact PI

CureGN-2: UNCPCC$779,808

U01 · FY2020 · DK · contact PI

Pathobiology of ANCA Glomerulonephritis: Targeting Adaptive and Innate Immune Processes for Precision Therapies$678,823

R01 · FY2020 · DK · contact PI

Renal Epidemiology Training Grant$221,573

T32 · FY2020 · DK · contact PI

Renal Epidemiology Training Grant$48,962

T32 · FY2020 · DK · contact PI

ANCA Glomerulonephritis: From Molecules to Man$1,677,110

P01 · FY2019 · DK · contact PI

CureGN-2: UNCPCC$779,808

U01 · FY2019 · DK · contact PI

Modulation of adaptive and innate immune responses influence the risk and severity of human ANCA GN.$363,341

P01 · FY2019 · DK · contact PI

Renal Epidemiology Training Grant$296,515

T32 · FY2019 · DK · contact PI

Administrative Core B$98,091

P01 · FY2019 · DK · contact PI

ANCA Glomerulonephritis: From Molecules to Man$1,683,140

P01 · FY2018 · DK · contact PI

Modulation of adaptive and innate immune responses influence the risk and severity of human ANCA GN.$363,341

P01 · FY2018 · DK · contact PI

Renal Epidemiology Training Grant$247,240

T32 · FY2018 · DK · contact PI

Administrative Core B$98,091

P01 · FY2018 · DK · contact PI

GDCN Clinical Center-Advancing Clinical Research in Primary Glomerular Diseases$1

UM1 · FY2018 · DK · contact PI

ANCA Glomerulonephritis: From Molecules to Man$1,676,555

P01 · FY2017 · DK · contact PI

GDCN Clinical Center-Advancing Clinical Research in Primary Glomerular Diseases$795,505

UM1 · FY2017 · DK · contact PI

Modulation of adaptive and innate immune responses influence the risk and severity of human ANCA GN.$363,341

P01 · FY2017 · DK · contact PI

Renal Epidemiology Training Grant$317,855

T32 · FY2017 · DK · contact PI

Administrative Core B$98,090

P01 · FY2017 · DK · contact PI

Renal Epidemiology Training Grant$2,753

T32 · FY2017 · DK · contact PI

ANCA Glomerulonephritis: From Molecules to Man$1,663,528

P01 · FY2016 · DK · contact PI

GDCN Clinical Center-Advancing Clinical Research in Primary Glomerular Diseases$760,564

UM1 · FY2016 · DK · contact PI

Modulation of adaptive and innate immune responses influence the risk and severity of human ANCA GN.$363,341

P01 · FY2016 · DK · contact PI

Renal Epidemiology Training Grant$265,188

T32 · FY2016 · DK · contact PI

Administrative Core B$93,987

P01 · FY2016 · DK · contact PI

ANCA Glomerulonephritis: From Molecules to Man$1,659,852

P01 · FY2015 · DK · contact PI

GDCN Clinical Center-Advancing Clinical Research in Primary Glomerular Diseases$798,688

UM1 · FY2015 · DK · contact PI

Modulation of adaptive and innate immune responses influence the risk and severity of human ANCA GN.$363,341

P01 · FY2015 · DK · contact PI

Renal Epidemiology Training Grant$334,705

T32 · FY2015 · DK · contact PI

GDCN Clinical Center-Advancing Clinical Research in Primary Glomerular Diseases$176,329

UM1 · FY2015 · DK · contact PI

Administrative Core B$93,987

P01 · FY2015 · DK · contact PI

ANCA Glomerulonephritis: From Molecules to Man$1,561,129

P01 · FY2014 · DK · contact PI

GDCN Clinical Center-Advancing Clinical Research in Primary Glomerular Diseases$833,572

UM1 · FY2014 · DK · contact PI

Biology of Remission and Relapse in ANCA Disease$352,185

P01 · FY2014 · DK · contact PI

Immunopathogenesis of ANCA Disease$337,293

P01 · FY2014 · DK · contact PI

Animal Model Studies of ANCA Disease Pathogenesis and its Modifiers$334,644

P01 · FY2014 · DK · contact PI

Renal Epidemiology Training Grant$276,354

T32 · FY2014 · DK · contact PI

Clinical Core$230,676

P01 · FY2014 · DK · contact PI

Translation of Knowledge on the Pathogenesis of ANCA Disease into Novel$220,703

P01 · FY2014 · DK · contact PI

GDCN Clinical Center-Advancing Clinical Research in Primary Glomerular Diseases$89,935

UM1 · FY2014 · DK · contact PI

Administrative Core$85,628

P01 · FY2014 · DK · contact PI

ANCA Glomerulonephritis: From Molecules to Man$1,454,972

P01 · FY2013 · DK · contact PI

GDCN Clinical Center-Advancing Clinical Research in Primary Glomerular Diseases$544,278

UM1 · FY2013 · DK · contact PI

Biology of Remission and Relapse in ANCA Disease$335,958

P01 · FY2013 · DK · contact PI

Immunopathogenesis of ANCA Disease$320,052

P01 · FY2013 · DK · contact PI

Animal Model Studies of ANCA Disease Pathogenesis and its Modifiers$319,202

P01 · FY2013 · DK · contact PI

Renal Epidemiology Training Grant$285,510

T32 · FY2013 · DK · contact PI

Clinical Core$213,144

P01 · FY2013 · DK · contact PI

Translation of Knowledge on the Pathogenesis of ANCA Disease into Novel$204,267

P01 · FY2013 · DK · contact PI

Administrative Core$62,349

P01 · FY2013 · DK · contact PI

ANCA Glomerulonephritis: From Molecules to Man$52,605

P01 · FY2013 · DK · contact PI

ANCA Glomerulonephritis: From Molecules to Man$1,511,345

P01 · FY2012 · DK · contact PI

Biology of Remission and Relapse in ANCA Disease$346,141

P01 · FY2012 · DK · contact PI

Immunopathogenesis of ANCA Disease$331,563

P01 · FY2012 · DK · contact PI

Animal Model Studies of ANCA Disease Pathogenesis and its Modifiers$330,171

P01 · FY2012 · DK · contact PI

Renal Epidemiology Training Grant$252,456

T32 · FY2012 · DK · contact PI

Clinical Core$221,974

P01 · FY2012 · DK · contact PI

Translation of Knowledge on the Pathogenesis of ANCA Disease into Novel$214,214

P01 · FY2012 · DK · contact PI

Administrative Core$67,282

P01 · FY2012 · DK · contact PI

ANCA Glomerulonephritis: From Molecules to Man$1,508,945

P01 · FY2011 · DK · contact PI

Renal Epidemiology Training Grant$250,841

T32 · FY2011 · DK · contact PI

Young Investigator Travel Awards: 15th International Vasculitis and ANCA Workshop$13,000

R13 · FY2011 · DK · contact PI

ANCA Glomerulonephritis: From Molecules to Man$1,525,267

P01 · FY2010 · DK · contact PI

Biology of Remission and Relapse in ANCA Disease$348,336

P01 · FY2010 · DK · contact PI

Renal Epidemiology Training Grant$186,227

T32 · FY2010 · DK · contact PI

Renal Epidemiology Training Grant$71,682

T32 · FY2010 · DK · contact PI

Administrative Core$69,461

P01 · FY2010 · DK · contact PI

ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN$854,715

P01 · FY2009 · DK · contact PI

Molecular genetics of ANCA glomerulonephritis$253,248

P01 · FY2009 · DK · contact PI

Renal Epidemiology Training Grant$232,698

T32 · FY2009 · DK · contact PI

Renal Epidemiology Training Grant$69,734

T32 · FY2009 · DK · contact PI

ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN$854,715

P01 · FY2008 · DK · contact PI

Molecular genetics of ANCA glomerulonephritis$253,248

P01 · FY2008 · DK · contact PI

Renal Epidemiology Training Grant$161,330

T32 · FY2008 · DK · contact PI

ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN$872,159

P01 · FY2007 · DK · contact PI

Renal Epidemiology Training Program$289,166

T32 · FY2007 · DK · contact PI

Molecular genetics of ANCA glomerulonephritis$258,414

P01 · FY2007 · DK · contact PI

ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN$898,207

P01 · FY2006 · DK · contact PI

Renal Epidemiology Training Program$269,162

T32 · FY2006 · DK · contact PI

Molecular genetics of ANCA glomerulonephritis$260,284

P01 · FY2006 · DK · contact PI

ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN$914,708

P01 · FY2005 · DK

Molecular genetics of ANCA glomerulonephritis$260,284

P01 · FY2005 · DK

Renal Epidemiology Training Program$157,362

T32 · FY2005 · DK

Renal Epidemiology Training Program$73,126

T32 · FY2005 · DK

ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN$1,070,474

P01 · FY2004 · DK

Renal Epidemiology Training Program$130,257

T32 · FY2004 · DK

ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN$124,088

P01 · FY2004 · DK

ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN$1,020,294

P01 · FY2003 · DK

RENAL EPIDEMIOLOGY TRAINING PROGRAM$133,233

T32 · FY2003 · DK

ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN$73,000

P01 · FY2003 · DK

ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN$30,904

P01 · FY2003 · DK

ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN$1,026,728

P01 · FY2002 · DK

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR IN PTS W/ SICKLE CELL NEPHROPATHY$190,747

M01 · FY2002 · RR

Molecular characterization of human ANCA and antigen$167,150

P01 · FY2002 · DK

Molecular characterization of human ANCA and antigen$167,150

P01 · FY2002 · DK

Molecular characterization of human ANCA and antigen$167,150

P01 · FY2002 · DK

ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN$120,569

P01 · FY2002 · DK

RENAL EPIDEMIOLOGY TRAINING PROGRAM$98,278

T32 · FY2002 · DK

ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN$91,406

P01 · FY2002 · DK

ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN$979,628

P01 · FY2001 · DK

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR IN PTS W/ SICKLE CELL NEPHROPATHY$294,555

M01 · FY2001 · RR

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR IN PTS W/ SICKLE CELL NEPHROPATHY$190,747

M01 · FY2001 · RR

Molecular characterization of human ANCA and antigen$167,150

P01 · FY2001 · DK

RENAL EPIDEMIOLOGY TRAINING PROGRAM$124,462

T32 · FY2001 · DK

ANCA GLOMERULONEPHRITIS: FROM MOLECULES TO MAN$1,002,901

P01 · FY2000 · DK

NEUTROPHIL AUTOANTIBODIES IN VASCULITIS AND NEPHRITIS$231,463

R01 · FY2000 · DK

Molecular characterization of human ANCA and antigen$167,150

P01 · FY2000 · DK

RENAL EPIDEMIOLOGY TRAINING PROGRAM$55,495

T32 · FY2000 · DK

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR IN PTS W/ SICKLE CELL NEPHROPATHY$0

M01 · FY2000 · RR

H5G1.1-MAB ON THE REDUCTION OF PROTEINUREA IN GLOMERULOPATHY$0

M01 · FY2000 · RR

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR IN PTS W/ SICKLE CELL NEPHROPATHY$0

M01 · FY2000 · RR

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR IN PTS W/ SICKLE CELL NEPHROPATHY$0

M01 · FY2000 · RR

ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR IN PTS W/ SICKLE CELL NEPHROPATHY$0

M01 · FY2000 · RR